Expanded Access: Programs & Possibilities

Current Expanded Access Programs

top of the page

There is no central listing of expanded access or compassionate use programs. If you find a program that’s not listed here, please let us know.

In general, the best way to access a treatment prior to FDA approval is through a clinical trial.

Experimental Drugs in Phase 3 Clinical Trials

top of the page

Remember:

• No cancer drug works for every patient who uses it
• Most cancer drugs have significant side effects
• We don't know if a new treatment will be better than the existing treatment until comparison trials are complete.

There are some new drugs - for example, Gleevec - which offer a dramatic improvement to standard treatments. Unfortunately, most new drugs don't fall into that category.

Experimental drugs in phase 3 clinical trials are generally the drugs closest to FDA review and possible approval. Companies tend to be most open to considering access outside of trials for drugs at this stage of development.

Remember, you cannot force companies to allow access. However, your call may get them thinking about either expanded access or single patient use. Contact us for help.

New Uses for Old Drugs

top of the page

Companies may apply to the FDA for approval of their drug in new forms of cancer, based on clinical trial results. This approval means that treatment for the new form of cancer is considered non-experimental and your insurance will cover costs.